A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition

Little is known regarding the basis for selection of the semi-invariant αβ T cell receptor (TCR) expressed by natural killer T (NKT) cells or how this mediates recognition of CD1d–glycolipid complexes. We have determined the structures of two human NKT TCRs that differ in their CDR3β composition and length. Both TCRs contain a conserved, positively charged pocket at the ligand interface that is lined by residues from the invariant TCR α- and semi-invariant β-chains. The cavity is centrally located and ideally suited to interact with the exposed glycosyl head group of glycolipid antigens. Sequences common to mouse and human invariant NKT TCRs reveal a contiguous conserved “hot spot” that provides a basis for the reactivity of NKT cells across species. Structural and functional data suggest that the CDR3β loop provides a plasticity mechanism that accommodates recognition of a variety of glycolipid antigens presented by CD1d. We propose a model of NKT TCR–CD1d–glycolipid interaction in which the invariant CDR3α loop is predicted to play a major role in determining the inherent bias toward CD1d. The findings define a structural basis for the selection of the semi-invariant αβ TCR and the unique antigen specificity of NKT cells.

[1]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[2]  S. Balk,et al.  Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain , 1993, The Journal of experimental medicine.

[3]  A. Lanzavecchia,et al.  An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells , 1994, The Journal of experimental medicine.

[4]  O. Lantz,et al.  An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans , 1994, The Journal of experimental medicine.

[5]  Y. Koezuka,et al.  KRN7000, a novel immunomodulator, and its antitumor activities. , 1995, Oncology research.

[6]  S. Kaufmann,et al.  IL-4 producing CD4+ TCRα βint liver lymphocytes: influence of thymus, β2-microglobulin and NK1.1 expression , 1995 .

[7]  S. Balk,et al.  Human T cells expressing an invariant Va24-JotQ TCRα are CD4- and heterogeneous with respect to TCRβ expression , 1996 .

[8]  Robyn L. Stanfield,et al.  An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex , 1996, Science.

[9]  Hiroshi Sato,et al.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. , 1997, Science.

[10]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[11]  Hiroshi Sato,et al.  Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .

[12]  Marie-Paule Lefranc,et al.  IMGT, the international ImMunoGeneTics database , 1997, Nucleic Acids Res..

[13]  S. Balk,et al.  Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997, The Journal of experimental medicine.

[14]  M. Kronenberg,et al.  Selective Ability of Mouse CD1 to Present Glycolipids: α-Galactosylceramide Specifically Stimulates Vα14+ NK T Lymphocytes , 1998, The Journal of Immunology.

[15]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[16]  M. Kronenberg,et al.  CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution , 1998, The Journal of experimental medicine.

[17]  L R Pease,et al.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. , 1998, Science.

[18]  M. Kronenberg,et al.  Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. , 1998, Journal of immunology.

[19]  S. Sekiya,et al.  A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. , 1999, International immunology.

[20]  M. McConville,et al.  CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. , 1999, Science.

[21]  Ian A. Wilson,et al.  Molecular Recognition of Lipid Antigens by T Cell Receptors , 1999, The Journal of experimental medicine.

[22]  I. Wilson,et al.  Structural requirements for antigen presentation by mouse CD1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Teyton,et al.  In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers , 2000, The Journal of experimental medicine.

[24]  A Vagin,et al.  An approach to multi-copy search in molecular replacement. , 2000, Acta crystallographica. Section D, Biological crystallography.

[25]  M. Kronenberg,et al.  Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers , 2000, The Journal of experimental medicine.

[26]  河野 鉄.  CD1d-restricted and TCR-mediated activation of V α14 NKT cells by glycosylceramides , 2000 .

[27]  S. Porcelli,et al.  CD1 proteins: targets of T cell recognition in innate and adaptive immunity. , 2000, Reviews in immunogenetics.

[28]  Cyrus Chothia,et al.  Canonical structures for the hypervariable regions of T cell αβ receptors 1 1 Edited by J. M. Thornton , 2000 .

[29]  A. Bendelac,et al.  CD1d-restricted mouse Vα14 and human Vα24 T cells: lymphocytes of innate immunity , 2000 .

[30]  H. Iijima,et al.  Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Vα14 NKT cells , 2001 .

[31]  鎌田 憲明.  Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Vα14 NKT cells , 2001 .

[32]  P. Kourilsky,et al.  Role of the Complementarity-Determining Region 3 (CDR3) of the TCR-β Chains Associated with the Vα14 Semi-Invariant TCR α-Chain in the Selection of CD4+ NK T Cells1 , 2001, The Journal of Immunology.

[33]  N. Fazilleau,et al.  Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Hardy,et al.  TCRβ Chain Influences But Does Not Solely Control Autoreactivity of Vα14J281T Cells1 , 2001, The Journal of Immunology.

[35]  I. Wilson,et al.  Fine Specificity of TCR Complementarity-Determining Region Residues and Lipid Antigen Hydrophilic Moieties in the Recognition of a CD1-Lipid Complex1 , 2002, The Journal of Immunology.

[36]  Ian A Wilson,et al.  The specificity of TCR/pMHC interaction. , 2002, Current opinion in immunology.

[37]  J. McCluskey,et al.  The 1.5 A crystal structure of a highly selected antiviral T cell receptor provides evidence for a structural basis of immunodominance. , 2002, Structure.

[38]  J. McCluskey,et al.  The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state. , 2002, Acta crystallographica. Section D, Biological crystallography.

[39]  K. Garcia,et al.  The Vα14 NKT Cell TCR Exhibits High-Affinity Binding to a Glycolipid/CD1d Complex1 , 2002, The Journal of Immunology.

[40]  M. Taniguchi,et al.  The NKT cell system: bridging innate and acquired immunity , 2003, Nature Immunology.

[41]  J. Whisstock,et al.  A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity , 2003 .

[42]  M. Lafleur,et al.  Structural Features of the Acyl Chain Determine Self-phospholipid Antigen Recognition by a CD1d-restricted Invariant NKT (iNKT) Cell* , 2003, Journal of Biological Chemistry.

[43]  M. Siomos,et al.  Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. , 2003, Immunity.

[44]  David I Stuart,et al.  A structural basis for immunodominant human T cell receptor recognition , 2003, Nature Immunology.

[45]  Mitchell Kronenberg,et al.  Surprisingly minor influence of TRAV11 (Vα14) polymorphism on NK T-receptor mCD1/α-galactosylceramide binding kinetics , 2003, Immunogenetics.

[46]  N. Segal,et al.  Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells , 2003, The Journal of experimental medicine.

[47]  H. Macdonald,et al.  Cutting Edge: Influence of the TCR Vβ Domain on the Avidity of CD1d:α-Galactosylceramide Binding by Invariant Vα14 NKT Cells1 , 2003, The Journal of Immunology.

[48]  H. Macdonald,et al.  Human Invariant Vα24-JαQ TCR Supports the Development of CD1d-Dependent NK1.1+ and NK1.1− T Cells in Transgenic Mice 1 , 2003, The Journal of Immunology.

[49]  Paul B. Savage,et al.  The Paradox of Immune Molecular Recognition of α-Galactosylceramide: Low Affinity, Low Specificity for CD1d, High Affinity for αβ TCRs1 , 2003, The Journal of Immunology.

[50]  Martyn D Winn,et al.  Macromolecular TLS refinement in REFMAC at moderate resolutions. , 2003, Methods in enzymology.

[51]  D. Pellicci,et al.  The Elusive NKT Cell Antigen--Is the Search Over? , 2004, Science.

[52]  Michael B Brenner,et al.  CD1: antigen presentation and T cell function. , 2004, Annual review of immunology.

[53]  G. Besra,et al.  The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[54]  H. Young,et al.  Dissociation of NKT Stimulation, Cytokine Induction, and NK Activation In Vivo by the Use of Distinct TCR-Binding Ceramides1 , 2004, The Journal of Immunology.

[55]  L. Kaer,et al.  Quantitative and Qualitative Differences in the In Vivo Response of NKT Cells to Distinct-and -Anomeric Glycolipids , 2004 .

[56]  Jelena S. Bezbradica,et al.  Quantitative and Qualitative Differences in the In Vivo Response of NKT Cells to Distinct α- and β-Anomeric Glycolipids1 , 2004, The Journal of Immunology.

[57]  R. Proia,et al.  Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.

[58]  S. Kaufmann,et al.  Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. Kronenberg,et al.  Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.

[60]  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections , 2005, Nature.

[61]  L. K. Ely,et al.  The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition , 2005, Nature Immunology.

[62]  J. McCluskey,et al.  CD1d antigen presentation: treats for NKT cells , 2005, Nature Immunology.

[63]  Mitchell Kronenberg,et al.  Toward an understanding of NKT cell biology: progress and paradoxes. , 2005, Annual review of immunology.

[64]  D. Ho,et al.  Recognition of bacterial glycosphingolipids by natural killer T cells , 2005, Nature.

[65]  R. Brutkiewicz,et al.  Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d‐specific ligands for NKT cells , 2005, European journal of immunology.

[66]  I. Wilson,et al.  Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor , 2005, Nature Immunology.

[67]  M. Kronenberg,et al.  Infection, autoimmunity, and glycolipids: T cells detect microbes through self-recognition. , 2005, Immunity.

[68]  M. Howarth,et al.  Site-specific labeling of cell surface proteins with biophysical probes using biotin ligase , 2005, Nature Methods.

[69]  Natalie A Borg,et al.  T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I–bound peptide , 2005, Nature Immunology.

[70]  D. Ho,et al.  Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[71]  A. Fersht,et al.  The crystal structure of human CD1d with and without α-galactosylceramide , 2005, Nature Immunology.

[72]  R. Webby,et al.  Lack of prominent peptide–major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations , 2005, Nature Immunology.

[73]  Natalie A Borg,et al.  High Resolution Structures of Highly Bulged Viral Epitopes Bound to Major Histocompatibility Complex Class I , 2005, Journal of Biological Chemistry.

[74]  Natalie A Borg,et al.  CTL Recognition of a Bulged Viral Peptide Involves Biased TCR Selection1 , 2005, The Journal of Immunology.